Neuropathy clinical trials at UCSF

• Single vs. Multiple Privigen Dose Regimens in Pediatric CIDP

  Sorry, in progress, not accepting new patients

  A randomized, open‑label, prospective, multicenter study designed to investigate 2 dose regimens in pediatric subjects 2 to < 17 years of age with confirmed or possible CIDP, either previously exposed to IVIG treatment or unexposed to IVIG treatment

  San Francisco, California and other locations

Last updated: April 2, 2020